Aspect Biosystems receives funding for cellular medicine project
The investment adds to the C$200m co-investment announced with Canada and British Columbia in 2024.
Drug Development
MSD secures EC clearance for Keytruda combination therapy for ovarian cancer
Merck KGaA acquires JSR chromatography business
Biocytogen and Sihuan partner to advance new therapeutics for weight loss
Telomir seeks FDA approval for Telomir-1 to treat breast cancer
Symeres and Ambagon collaborate for colorectal cancer molecules
Teva receives FDA approval for Prolia biosimilar
uBriGene and Cellinfinity BIO collaborate to accelerate in vivo CAR-T therapies
